Thus, when targeted NGS results were compared to results obtained by real-time PCR for tumor samples from patients with NSCLC, the two methods had high concordance rates for the three genes tested: 96.3% for EGFR, 98.7% for KRAS, and 100% for BRAF [80]. Here, KRAS is linked to non-small cell lung carcinoma.